Rajesh (R.K.) Khosla is Chief Business Officer of Black Beret Life Sciences, LLC.
R.K. was most recently CEO at Laguna Pharmaceuticals (formerly ChanRx Corp.), a company developing a multi-channel drug for the treatment of atrial fibrillation/atrial flutter, taking it through a very successful Phase 2b and raising $30M for a Phase 3 study. Simultaneously, he was CEO-in-Residence at BioEnterprise Corp. helping companies to accelerate their growth to benefit the Northeastern Ohio economy. Previously, R.K. was CEO of PeriTec Biosciences Ltd., a medical device spin-off of the Cleveland Clinic Foundation. Within a 4-year period, the company advanced from animal studies to completing 20 patients in the First-in-Man study and 10 patients in the Second-in-Man study.
R.K. has a wide background in finance, entrepreneurship and venture capital. Highlights include two years as a Principal concentrating on wireless technologies at Crystal Ventures, a tech venture fund with offices in Cleveland, Palo Alto, Singapore & Taipei. He was also CFO and Director of Back Office Operations for All Wound Up, which exited to Borders Group in March 1999. All Wound Up, a seasonal toy retailing concept, was the winner of the Weatherhead 100 award for fastest growing company in Northern Ohio from 1994-1998. R.K. started his career at National City Corp. (now PNC) in Corporate Banking with the majority of his time being spent in Merchant Banking concentrating on off balance sheet vehicles and Mergers & Acquisitions including the takeover of Ohio Bancorp.
Given his experience from all sides of the financing table as well as his operating roles, in his consulting practice, R.K. has been providing C-suite guidance to clients, both companies as well as venture funds, in various technology fields since 2005.
R.K. earned an Electrical Engineering/Applied Physics degree, summa cum laude, with a minor in Economics from Case Western Reserve University. In addition, he has an MBA with a concentration in Finance from the Yale University School of Management with Letters of Distinction provided in Financial Accounting and Managerial Accounting.